Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ani Pharmaceuticals (ANIP) Shares Outstanding (Diluted Average) (2016 - 2026)

Ani Pharmaceuticals' Shares Outstanding (Diluted Average) history spans 16 years, with the latest figure at $21.2 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 9.89% to $21.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $21.2 million, a 9.89% increase, with the full-year FY2025 number at $21.2 million, up 9.89% from a year prior.
  • Shares Outstanding (Diluted Average) hit $21.2 million in Q4 2025 for Ani Pharmaceuticals, up from $21.1 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for ANIP hit a ceiling of $21.2 million in Q4 2025 and a floor of $12.0 million in Q1 2021.
  • Historically, Shares Outstanding (Diluted Average) has averaged $17.2 million across 5 years, with a median of $17.8 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): grew 0.92% in 2021 and later soared 35.09% in 2022.
  • Tracing ANIP's Shares Outstanding (Diluted Average) over 5 years: stood at $12.6 million in 2021, then rose by 29.09% to $16.3 million in 2022, then grew by 11.89% to $18.2 million in 2023, then rose by 6.18% to $19.3 million in 2024, then rose by 9.89% to $21.2 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for ANIP at $21.2 million in Q4 2025, $21.1 million in Q3 2025, and $20.2 million in Q2 2025.